Cargando…

U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study

BACKGROUND: The optimal serum magnesium level of patients undergoing hemodialysis (HD) with cognitive impairment is still unclear. This study aimed to evaluate the association between serum magnesium levels and mild cognitive impairment among HD patients. METHODS: This was a multicenter observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yuqi, Long, Yanjun, Yuan, Jing, Zha, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334860/
https://www.ncbi.nlm.nih.gov/pubmed/37427770
http://dx.doi.org/10.1080/0886022X.2023.2231084
_version_ 1785070937034457088
author Yang, Yuqi
Long, Yanjun
Yuan, Jing
Zha, Yan
author_facet Yang, Yuqi
Long, Yanjun
Yuan, Jing
Zha, Yan
author_sort Yang, Yuqi
collection PubMed
description BACKGROUND: The optimal serum magnesium level of patients undergoing hemodialysis (HD) with cognitive impairment is still unclear. This study aimed to evaluate the association between serum magnesium levels and mild cognitive impairment among HD patients. METHODS: This was a multicenter observational study. Patients undergoing hemodialysis from 22 dialysis centers in Guizhou Province, China were recruited into the study. HD patients were divided into five groups according to serum magnesium quintile. Cognitive function was measured with Mini Mental State Examination. The outcome was an incident mild cognitive impairment (MCI). Multivariate logistic regression analysis, restricted cubic spline and subgroup analysis were applied to explore the association of serum magnesium level with MCI. RESULTS: Among 3562 HD patients (mean age 54.3 years, 60.1% male), the prevalence of MCI was 27.2%. After adjusting for confounders, serum magnesium 0.41–0.83 mmol/L [odds ratios (OR) 1.55, 95% confidence interval (CI): 1.10–2.18] had a higher risk of MCI compared with serum magnesium of 1.19–1.45 mmol/L. A U-shaped association was identified between the serum magnesium and incident MCI (P for non-linearity = 0.004). The optimal range of magnesium level with the lowest risk of MCI was 1.12–1.24 mmol/L. As the serum magnesium level was lower than 1.12 mmol/L, the risk of MCI decreased by 24% per standard deviation (SD) increase in serum magnesium (OR 0.76, 95%CI: 0.62–0.93); when the serum magnesium level exceeds 1.24 mmol/L, a rise per SD increased the risk of MCI by 21% (OR = 1.20, 95%CI: 1.02–1.43). Subgroup analyses demonstrated that the associations were robust among individuals with low educational level, smoking, living alone, no working, and without hypertension or diabetes. CONCLUSIONS: Serum magnesium has a U-shaped association with MCI among HD patients. Both lower and higher serum magnesium can increase the risk of MCI for this population specifically. The optimal serum magnesium range with the lowest risk of MCI was 1.12–1.24 mmol/L.
format Online
Article
Text
id pubmed-10334860
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-103348602023-07-12 U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study Yang, Yuqi Long, Yanjun Yuan, Jing Zha, Yan Ren Fail Clinical Study BACKGROUND: The optimal serum magnesium level of patients undergoing hemodialysis (HD) with cognitive impairment is still unclear. This study aimed to evaluate the association between serum magnesium levels and mild cognitive impairment among HD patients. METHODS: This was a multicenter observational study. Patients undergoing hemodialysis from 22 dialysis centers in Guizhou Province, China were recruited into the study. HD patients were divided into five groups according to serum magnesium quintile. Cognitive function was measured with Mini Mental State Examination. The outcome was an incident mild cognitive impairment (MCI). Multivariate logistic regression analysis, restricted cubic spline and subgroup analysis were applied to explore the association of serum magnesium level with MCI. RESULTS: Among 3562 HD patients (mean age 54.3 years, 60.1% male), the prevalence of MCI was 27.2%. After adjusting for confounders, serum magnesium 0.41–0.83 mmol/L [odds ratios (OR) 1.55, 95% confidence interval (CI): 1.10–2.18] had a higher risk of MCI compared with serum magnesium of 1.19–1.45 mmol/L. A U-shaped association was identified between the serum magnesium and incident MCI (P for non-linearity = 0.004). The optimal range of magnesium level with the lowest risk of MCI was 1.12–1.24 mmol/L. As the serum magnesium level was lower than 1.12 mmol/L, the risk of MCI decreased by 24% per standard deviation (SD) increase in serum magnesium (OR 0.76, 95%CI: 0.62–0.93); when the serum magnesium level exceeds 1.24 mmol/L, a rise per SD increased the risk of MCI by 21% (OR = 1.20, 95%CI: 1.02–1.43). Subgroup analyses demonstrated that the associations were robust among individuals with low educational level, smoking, living alone, no working, and without hypertension or diabetes. CONCLUSIONS: Serum magnesium has a U-shaped association with MCI among HD patients. Both lower and higher serum magnesium can increase the risk of MCI for this population specifically. The optimal serum magnesium range with the lowest risk of MCI was 1.12–1.24 mmol/L. Taylor & Francis 2023-07-10 /pmc/articles/PMC10334860/ /pubmed/37427770 http://dx.doi.org/10.1080/0886022X.2023.2231084 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Clinical Study
Yang, Yuqi
Long, Yanjun
Yuan, Jing
Zha, Yan
U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title_full U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title_fullStr U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title_full_unstemmed U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title_short U-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
title_sort u-shaped association of serum magnesium with mild cognitive impairment among hemodialysis patients: a multicenter study
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334860/
https://www.ncbi.nlm.nih.gov/pubmed/37427770
http://dx.doi.org/10.1080/0886022X.2023.2231084
work_keys_str_mv AT yangyuqi ushapedassociationofserummagnesiumwithmildcognitiveimpairmentamonghemodialysispatientsamulticenterstudy
AT longyanjun ushapedassociationofserummagnesiumwithmildcognitiveimpairmentamonghemodialysispatientsamulticenterstudy
AT yuanjing ushapedassociationofserummagnesiumwithmildcognitiveimpairmentamonghemodialysispatientsamulticenterstudy
AT zhayan ushapedassociationofserummagnesiumwithmildcognitiveimpairmentamonghemodialysispatientsamulticenterstudy